Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA298425
Max Phase: Preclinical
Molecular Formula: C7H10O6
Molecular Weight: 190.15
Molecule Type: Small molecule
Associated Items:
ID: ALA298425
Max Phase: Preclinical
Molecular Formula: C7H10O6
Molecular Weight: 190.15
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC1=C(O)C(=O)OC1C(O)CO
Standard InChI: InChI=1S/C7H10O6/c1-12-6-4(10)7(11)13-5(6)3(9)2-8/h3,5,8-10H,2H2,1H3
Standard InChI Key: HFSCYDMAVALOIA-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 190.15 | Molecular Weight (Monoisotopic): 190.0477 | AlogP: -1.32 | #Rotatable Bonds: 3 |
Polar Surface Area: 96.22 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.11 | CX Basic pKa: | CX LogP: -1.80 | CX LogD: -1.88 |
Aromatic Rings: 0 | Heavy Atoms: 13 | QED Weighted: 0.48 | Np Likeness Score: 2.02 |
1. Abell AD, Ratcliffe MJ, Gerrard J.. (1998) Ascorbic acid-based inhibitors of alpha-amylases., 8 (13): [PMID:9873419] [10.1016/s0960-894x(98)00298-4] |
Source(1):